Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial-Reference-Cited by-同舟云学术

Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial

Published:2009-08 Issue:8 Volume:11 Page:804-812
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Schweizer A.,Dejager S.,Bosi E.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2009.01051.x/fullpdf

Reference32 articles.

1. 1 Center for Disease Control and Prevention. National diabetes surveillance system. 2007. Available from URL: http://www.cdc.gov/diabetes/statistics/prev/national/figbyage.htm. Accessed 3 September 2007.

2. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030;Wild;Diabetes Care,2004

3. Management of type 2 diabetes in the elderly: special considerations;Rosenstock;Drugs Aging,2001

4. Treatment of patients over 64 years of age with type 2 diabetes: experience from nateglinide pooled database retrospective analysis;Del Prato;Diabetes Care,2003

5. The burden and treatment of diabetes in elderly individuals in the U.S;Selvin;Diabetes Care,2006

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of glucose-lowering medications in older people: a comprehensive systematic review and network meta-analysis of randomized controlled trials;Age and Ageing;2024-08

2. Prevention of Chronic Kidney Disease and Its Complications in Older Adults;Drugs & Aging;2024-06-26

3. A Systematic Study of Pyracantha crenulata Phytoconstituents for their Anti-Diabetic Activity Using Computational Techniques;Current Analytical Chemistry;2024-06

4. PERSPECTIVES OF CLINICAL EXPERTS ON THE CURRENT USAGE PATTERNS AND THE PREFERENCE OF VILDAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES;Innovare Journal of Medical Sciences;2024-03-12

5. Synergistic Benefits: Exploring the Anti-Virulence Effects of Metformin/Vildagliptin Antidiabetic Combination against Pseudomonas aeruginosa via Controlling Quorum Sensing Systems;Biomedicines;2023-05-14